{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:43:52Z","timestamp":1780361032928,"version":"3.54.1"},"reference-count":36,"publisher":"Annals of Laboratory Medicine","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["new.annlabmed.org"],"crossmark-restriction":true},"short-container-title":["Ann Lab Med"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.3343\/alm.2020.40.5.361","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T02:38:09Z","timestamp":1587091089000},"page":"361-369","update-policy":"https:\/\/doi.org\/10.3343\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens"],"prefix":"10.3343","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2213-2579","authenticated-orcid":false,"given":"Heyjin","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Korea Cancer Center Hospital, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3741-4613","authenticated-orcid":false,"given":"Hee-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7542-5551","authenticated-orcid":false,"given":"Sun-Hee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27150","reference":[{"key":"ref1","first-page":"335","volume-title":"","author":"Swerdlow","year":"2017"},{"key":"ref2","first-page":"5019","volume-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","author":"Campo","year":"2011"},{"key":"ref3","volume-title":"Aggressive B-cell lymphomas: how many categories do we need?","author":"Said","year":"2013"},{"key":"ref4","first-page":"299","volume-title":"Biology of double-hit B-cell lymphomas","author":"Lindsley","year":"2012"},{"key":"ref5","first-page":"327","volume-title":"B-cell lymphomas with concurrent <italic>IGH<\/italic>-<italic>BCL2<\/italic> and <italic>MYC<\/italic> rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma","author":"Snuderl","year":"2010"},{"key":"ref6","first-page":"891","volume-title":"Double hit lymphoma: the MD Anderson Cancer Center clinical experience","author":"Oki","year":"2014"},{"key":"ref7","first-page":"145","volume-title":"B-cell lymphomas with <italic>MYC<\/italic>\/8q24 rearrangements and <italic>IGH@BCL2<\/italic>\/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome","author":"Li","year":"2012"},{"key":"ref8","first-page":"233","volume-title":"Double hit lymphoma: how do we define it and how do we treat it?","author":"Merron","year":"2018"},{"key":"ref9","first-page":"1263","volume-title":"Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy","author":"Carbone","year":"2014"},{"key":"ref10","first-page":"590","volume-title":"How I treat double-hit lymphoma","author":"Friedberg","year":"2017"},{"key":"ref11","first-page":"563","volume-title":"Emerging strategies in treating double hit lymphomas","author":"Nabhan","year":"2017"},{"key":"ref12","first-page":"410","volume-title":"Identification of \u201cDouble Hit\u201d lymphomas using updated WHO criteria: insights from routine <italic>MYC<\/italic> immunohistochemistry in 272 consecutive cases of aggressive B-cell lymphomas","author":"Sakr","year":"2019"},{"key":"ref13","first-page":"280","volume-title":"Approach to the diagnosis and treatment of high-grade B-cell lymphomas with <italic>MYC<\/italic> and <italic>BCL2<\/italic> and\/or <italic>BCL6<\/italic> rearrangements","author":"Sesques","year":"2017"},{"key":"ref14","first-page":"2319","volume-title":"Double-hit B-cell lymphomas","author":"Aukema","year":"2011"},{"key":"ref15","first-page":"2060","volume-title":"High-grade B-cell lymphoma with <italic>MYC<\/italic> and <italic>BCL2<\/italic> and\/or <italic>BCL6<\/italic> rearrangements with diffuse large B-cell lymphoma morphology","author":"Scott","year":"2018"},{"key":"ref16","first-page":"196","volume-title":"Diffuse large B-Cell lymphoma version 1.2016","author":"Zelenetz","year":"2016"},{"key":"ref17","first-page":"737","volume-title":"Bone marrow trephine biopsy","author":"Bain","year":"2001"},{"key":"ref18","first-page":"214","volume-title":"Staging bone marrow in diffuse large B-cell lymphoma: the role of ancillary investigations","author":"Talaulikar","year":"2009"},{"key":"ref19","first-page":"349","volume-title":"ICSH guidelines for the standardization of bone marrow specimens and reports","author":"Lee","year":"2008"},{"key":"ref20","first-page":"159","volume-title":"Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin\u2019s lymphomas","author":"Mazur","year":"2004"},{"key":"ref21","first-page":"187","volume-title":"Bone marrow flow cytometry in staging of patients with B-cell non-Hodgkin lymphoma","author":"Kim","year":"2015"},{"key":"ref22","first-page":"776","volume-title":"Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients","author":"Morice","year":"2008"},{"key":"ref23","first-page":"275","volume-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","author":"Hans","year":"2004"},{"key":"ref24","first-page":"190","volume-title":"Introduction and overview of the classification of lymphoid neoplasms","author":"Jaffe","year":"2017"},{"key":"ref25","volume-title":"Clinical flow cytometry: state-of-the-art and new approaches","author":"Dorfman","year":"2017"},{"key":"ref26","first-page":"258","volume-title":"\u2018Double-Hit\u2019 mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression","author":"Wu","year":"2010"},{"key":"ref27","first-page":"137","volume-title":"Flow cytometric evaluation of double\/triple hit lymphoma","author":"Roth","year":"2016"},{"key":"ref28","first-page":"718","volume-title":"A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma","author":"Schniederjan","year":"2010"},{"key":"ref29","first-page":"2466","volume-title":"<italic>MYC<\/italic>-<italic>IG<\/italic> rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study","author":"Copie-Bergman","year":"2015"},{"key":"ref30","first-page":"140","volume-title":"Diffuse large B-cell lymphoma with <italic>MYC<\/italic> gene rearrangements: current perspective on treatment of diffuse large B-cell lymphoma with <italic>MYC<\/italic> gene rearrangements; case series and review of the literature","author":"de Jonge","year":"2016"},{"key":"ref31","first-page":"631","volume-title":"Sole rearrangement but not amplification of <italic>MYC<\/italic> is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable","author":"Landsburg","year":"2016"},{"key":"ref32","first-page":"141","volume-title":"FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue","author":"Ventura","year":"2006"},{"key":"ref33","first-page":"71","volume-title":"Detection of cryptic and variant <italic>IGH<\/italic>-<italic>MYC<\/italic> rearrangements in high-grade non-Hodgkin\u2019s lymphoma by fluorescence in situ hybridization: implications for cytogenetic testing","author":"May","year":"2010"},{"key":"ref34","first-page":"418","volume-title":"<italic>MYC<\/italic> status determination in aggressive B-cell lymphoma: the impact of FISH probe selection","author":"Mu\u00f1oz-M\u00e1rmol","year":"2013"},{"key":"ref35","first-page":"2755","volume-title":"High-resolution architecture and partner genes of <italic>MYC<\/italic> rearrangements in lymphoma with DLBCL morphology","author":"Chong","year":"2018"},{"key":"ref36","volume-title":"Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas","author":"Sarkozy","year":"2015"}],"container-title":["Annals of Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.annlabmed.org\/upload\/pdf\/alm-2020-40-5-361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.annlabmed.org\/journal\/view.html?volume=40&number=5&spage=361","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.annlabmed.org\/upload\/pdf\/alm-2020-40-5-361.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T03:56:50Z","timestamp":1604030210000},"score":1,"resource":{"primary":{"URL":"http:\/\/annlabmed.org\/journal\/view.html?doi=10.3343\/alm.2020.40.5.361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9,1]]}},"alternative-id":["10.3343\/alm.2020.40.5.361"],"URL":"https:\/\/doi.org\/10.3343\/alm.2020.40.5.361","relation":{},"ISSN":["2234-3806","2234-3814"],"issn-type":[{"value":"2234-3806","type":"print"},{"value":"2234-3814","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"http:\/\/annlabmed.org\/journal\/view.html?doi=10.3343\/alm.2020.40.5.361","URL":"http:\/\/annlabmed.org\/journal\/view.html?doi=10.3343\/alm.2020.40.5.361","name":"the_journal","label":"Ann Lab Med","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2019-10-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"\ufffd\ufffd 2020 The Korean Society for Laboratory Medicine","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}